Zoetis Inc.

ZTS

US98978V1035

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2026-02-06 pm EST			5-day change	1st Jan Change
127.42 ^USD	+0.54%		+2.08%	+1.27%

Feb. 05	Zoetis Keeps Quarterly Dividend at $0.53 a Share, Payable June 2 to Stockholders of Record April 20	MT
Feb. 05	Zoetis Inc. Declares Second Quarter 2026 Dividend, Payable on June 2, 2026	CI

Zoetis CEO on Animal Health, Vaccines and Beef Prices

Published on 01/12/2026 at 05:26 pm EST

MT Newswires

ZOETIS INC.

+0.54%

FEEDER CATTLE FUTURE (GF) - CMG/C1

-0.08%

Zoetis (ZTS) CEO Kristin Peck says higher protein demand is driving demand for livestock vaccines. She speaks with Katie Greifeld at JPMorgan's annual health-care conference in San Francisco.

Bloomberg videos, provided by MT Newswires

Stocks mentioned in the article

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	ZOETIS INC.	127.42USD	+0.54%	+2.08%	56.15B
	FEEDER CATTLE FUTURE (GF) - CMG/C1	286.70USc	-0.08%	+0.16%	-

Latest news about Zoetis Inc.

Feb. 05	Zoetis Keeps Quarterly Dividend at $0.53 a Share, Payable June 2 to Stockholders of Record April 20	MT
Feb. 05	Zoetis Inc. Declares Second Quarter 2026 Dividend, Payable on June 2, 2026	CI
Feb. 04	Freshpet, Inc. Announces CFO Changes, Effective February 9, 2026	CI
Feb. 02	IDEXX forecasts 2026 revenue, profit above estimates on strong demand for pet diagnostics	RE
Jan. 29	UBS Adjusts Price Target on Zoetis to $136 From $141, Maintains Neutral Rating	MT
Jan. 22	Escalate, De-Escalate, Repeat
Jan. 22	Piper Sandler Downgrades Zoetis to Neutral From Overweight, Adjusts Price Target to $135 From $190	MT
Jan. 22	Analyst recommendations: Datadog, Albemarle, Halliburton, Netflix…
Jan. 12	Zoetis CEO on Animal Health, Vaccines and Beef Prices	MT
Jan. 12	Zoetis Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 10:30 AM
Dec. 17	Morgan Stanley Adjusts Zoetis Price Target to $160 From $175, Maintains Overweight Rating	MT
Dec. 16	Sector Update: Health Care Stocks Edge Higher Premarket Tuesday	MT
Dec. 16	The Fed's Favorite Numbers?
Dec. 16	Zoetis Prices $1.75 Billion Convertible Notes Offering	MT
Dec. 16	Zoetis says co priced offering of $1.75 billion aggregate principal amount of 0.25% convertible senior notes due 2029	RE
Dec. 15	Zoetis to Offer $1.75 Billion Convertible Notes Offering	MT
Dec. 15	Zoetis announces proposed $1.75 billion convertible senior notes offering	RE
Dec. 15	BofA Securities Downgrades Zoetis to Neutral From Buy	MT
Dec. 15	Zoetis shares fall 2.6% premarket after co announces proposed $1.75 billion convertible senior notes offering	RE
Dec. 11	Zoetis Ups Quarterly Dividend to $0.53 per Share, Payable Mar. 3 to Holders of Record on Jan. 20	MT
Dec. 11	Zoetis declares first quarter 2026 dividend; board approves 6% payment increase	RE
Dec. 11	Zoetis Inc. Declares Dividend for the First Quarter of 2026, Payable on March 3, 2026	CI
Dec. 10	HSBC Adjusts Zoetis Price Target to $140 From $180, Maintains Buy Rating	MT
Dec. 09	Barclays Initiates Zoetis at Equalweight With $136 Price Target	MT
Dec. 05	Zoetis Says Health Canada Approves Long-Lasting Cat Osteoarthritis Drug	MT

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.

Employees

13,800

Sector

Pharmaceuticals

Calendar

Feb. 12 - Q4 2025 Earnings Release

More about the company